What is the recommended acute and secondary management for a patient with lateral medullary syndrome (Wallenberg syndrome)?

Lateral Medullary Syndrome (Wallenberg Syndrome) Management

For acute management of lateral medullary syndrome, initiate aspirin 160-300 mg within 24-48 hours if the patient is not a candidate for thrombolysis, and consider dual antiplatelet therapy (aspirin plus clopidogrel) for 21 days if presenting with minor stroke symptoms (NIHSS ≤3). 1

Acute Phase Management

Thrombolysis Consideration

• IV alteplase (tPA) should be considered if the patient presents within the therapeutic window and meets eligibility criteria, though the evidence for its use specifically in vertebral artery dissection-related Wallenberg syndrome is limited 1, 2
• The reality is that most lateral medullary syndrome patients receive only 2.7% thrombolysis rate in clinical practice, largely because these strokes often present with minor to moderate symptoms (73% with NIHSS 1-4) that may not trigger immediate thrombolysis consideration 3
• Do not substitute aspirin for thrombolysis in otherwise eligible patients 1

Antiplatelet Therapy

The cornerstone of acute treatment is antiplatelet therapy:

• Single antiplatelet therapy (SAPT): Aspirin 160-300 mg is the standard initial treatment, administered orally, rectally, or via nasogastric tube if swallowing is unsafe 1

  • In practice, 68.5% of lateral medullary syndrome patients receive SAPT 3

• Dual antiplatelet therapy (DAPT): For patients presenting with minor stroke symptoms, aspirin plus clopidogrel for 21 days initiated within 24 hours provides early secondary stroke prevention for up to 90 days 1

  • Approximately 29.6% of lateral medullary syndrome patients receive DAPT 3
  • Ticagrelor is not recommended over aspirin in acute minor stroke treatment 1

Anticoagulation

• Low molecular weight heparin (LMWH) may be reasonable for short-term use in cases with vertebral artery dissection and nonocclusive intraluminal thrombus, though the evidence remains uncertain 1, 4
• The usefulness of urgent anticoagulation for severe vertebral artery stenosis is not well established 1
• Glycoprotein IIb/IIIa receptor antagonists (abciximab) should not be used as they are potentially harmful 1

Secondary Prevention and Etiology-Specific Management

Identify the Underlying Cause

The etiology dictates long-term management:

• Large vessel atherosclerotic disease (40.7%): Aggressive risk factor modification, statin therapy, and antiplatelet agents 3
• Small vessel disease (37.6%): Blood pressure control and antiplatelet therapy 3
• Arterial dissection (5.5%): Consider anticoagulation vs antiplatelet therapy; the optimal approach remains controversial 3, 5
• Cardioembolic (detected in 1.85% via Holter monitoring): Anticoagulation if atrial fibrillation is identified 3

Cardiac Monitoring

• Perform 48-hour Holter monitoring to detect paroxysmal atrial fibrillation, as this was identified in 1.85% of cases and changes management to anticoagulation 3

Diagnostic Pitfalls and Recognition

High Index of Suspicion Required

Lateral medullary syndrome represents only 3.7% of all ischemic strokes and can present with non-specific symptoms that mimic benign conditions 3:

• Classic presentation includes: Vertigo (94.4%), limb ataxia (84.3%), dysarthria (44.4%), ipsilateral facial sensory loss (32.4%), contralateral limb sensory loss (25%), dysphagia (19.4%), and hiccups (13%) 3
• Delayed symptom onset can occur: Symptoms may evolve over days, with initial presentations showing only vertigo before classic lateral medullary features develop 6
• Initial CT head is often negative; MRI with diffusion-weighted imaging (DWI) is essential for diagnosis 3, 4, 7

Common Misdiagnosis Scenarios

• Patients presenting with isolated vertigo, nausea, and vomiting may be misdiagnosed with benign conditions (vestibular neuritis, UTI) 7
• Use the posterior NIHSS (POST-NIHSS) for better assessment of posterior circulation strokes 3

Prognosis and Rehabilitation

• 47% of patients are discharged home with functional independence (mRS 0-2), while 51.9% require transfer to rehabilitation facilities 3
• At follow-up, 74% achieve functional independence (mRS 0-2) 3
• Dysphagia is a significant complication occurring in 19.4% of cases and may require gastrostomy tube placement in severe cases 3, 8
• Overall prognosis is favorable with early recognition and treatment 4, 5

Key Management Points

• 25% of cases have extramedullary involvement, predominantly cerebellar (17.6%), which may worsen prognosis 3
• Early physical rehabilitation is critical for recovery 4
• Symptoms like dysarthria and dysphagia often improve significantly within the first week of treatment 4